Notice of Approval of Supplemental New Animal Drug Application; Moxidectin

ローカル自動翻訳 · 情報源の原言語

概要

The Food and Drug Administration (FDA) is providing notice that it has approved a supplemental new animal drug application (NADA) filed by Fort Dodge Animal Health, Division of Wyeth. The approved NADA provides for the veterinary prescription use of a sustained-release injectable moxidectin formulation for prevention of heartworm disease and treatment of existing hookworm infections in dogs. The supplemental NADA adds animal safety information to product labeling.

情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →

Notice of Approval of Supplemental New Animal Drug Application; Moxidectin

Office of Management and Budget (OMB) に提出された情報収集活動; Food and Drug Administration (FDA) の提出書類の提出; Customer/Partner Customer Service Satisfaction Surveys に関するコメントの要求

CDCのデータ収集計画についての意見募集

Office of the National Coordinator for Health Information Technology; Health Information Technology Advisory Committee; エンタイントにそすにしたプログルにしたプログにプログを定义にしたプログに。